Approvals/NMPA/Recombinant Human Tissue-type Plasminogen Activator Derivative for Injection

Approved

生物制品

Recombinant Human Tissue-type Plasminogen Activator Derivative for Injection

华润昂德生物药业有限公司🇨🇳 National Medical Products Administration

Approval Id: 7Leafp72GHk
Approval Number: 国药准字S20070023
Generic Name: 注射用重组人组织型纤溶酶原激酶衍生物
Generic Name En: Recombinant Human Tissue-type Plasminogen Activator Derivative for Injection
Trade Name: 瑞通立
Brand Name: 瑞通立
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 18mg/10ml/支
Reg Date: 2022-01-29
Company Name: 华润昂德生物药业有限公司
Company Address: 山东省东阿县阿胶街78号
Production Company Name: 华润昂德生物药业有限公司
Production Company Address: 山东省东阿县阿胶街78号
Company Detail Path: /organization/hua-run-ang-de-sheng-wu-yao-ye-you-xian-gong-si
Production Company Detail Path: /organization/hua-run-ang-de-sheng-wu-yao-ye-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jan 29, 2022

Approval ID

7Leafp72GHk

Type

生物制品